Adage Capital Partners GP »

Ocular Therapeutix shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.4M 375k 9.10

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
BlackRock
Vanguard Group
Opaleye Management
Logos Global Management
Citadel Advisors
Perceptive Advisors
Geode Capital Management
Octagon Capital Advisors
Deltec Asset Management
Franklin Resources
Dr. Jeffrey R. Jay, M.D.
Morgan Stanley
Nuveen Asset Management

View all funds holding Ocular Therapeutix